Polyamines and Cancer

Elisabetta Damiani, Heather M Wallace

Research output: Chapter in Book/Report/Conference proceedingChapter

6 Citations (Scopus)

Abstract

This chapter provides an overview of how the polyamine pathway has been exploited as a target for the treatment and prevention of multiple forms of cancer, since this pathway is disrupted in all cancers. It is divided into three main sections. The first explores how the polyamine pathway has been targeted for chemotherapy, starting from the first drug to target it, difluoromethylornithine (DFMO) to the large variety of polyamine analogues that have been synthesised and tested throughout the years with all their potentials and pitfalls. The second section focuses on the use of polyamines as vectors for drug delivery. Knowing that the polyamine transport system is upregulated in cancers and that polyamines naturally bind to DNA, a range of polyamine analogues and polyamine-like structures have been synthesised to target epigenetic regulators, with encouraging results. Furthermore, the use of polyamines as transport vectors to introduce toxic/bioactive/fluorescent agents more selectively to the intended target in cancer cells is discussed. The last section concentrates on chemoprevention, where the different strategies that have been undertaken to interfere with polyamine metabolism and function for antiproliferative intervention are outlined and discussed.

Original languageEnglish
Title of host publicationPolyamines
Subtitle of host publicationMethods and Protocols
EditorsR Alcázar, A Tiburcio
Place of PublicationNew York
PublisherHumana Press
Pages469-488
Number of pages20
ISBN (Electronic)978-1-4939-7398-9
ISBN (Print)978-1-4939-7397-2
DOIs
Publication statusPublished - 2018

Publication series

NameMethods in Molecular Biology
PublisherSpringer
Volume1694
ISSN (Print)1064-3745

Fingerprint

Polyamines
Neoplasms
Eflornithine
Poisons
Chemoprevention
Fluorescent Dyes
Epigenomics
Pharmaceutical Preparations
Drug Therapy
DNA

Keywords

  • Polyamines
  • Cancer
  • Chemoprevention
  • Chemotherapy
  • Drug Delivery

Cite this

Damiani, E., & Wallace, H. M. (2018). Polyamines and Cancer. In R. Alcázar, & A. Tiburcio (Eds.), Polyamines: Methods and Protocols (pp. 469-488). (Methods in Molecular Biology; Vol. 1694). New York: Humana Press. https://doi.org/10.1007/978-1-4939-7398-9_39

Polyamines and Cancer. / Damiani, Elisabetta; Wallace, Heather M.

Polyamines: Methods and Protocols. ed. / R Alcázar; A Tiburcio . New York : Humana Press, 2018. p. 469-488 (Methods in Molecular Biology; Vol. 1694).

Research output: Chapter in Book/Report/Conference proceedingChapter

Damiani, E & Wallace, HM 2018, Polyamines and Cancer. in R Alcázar & A Tiburcio (eds), Polyamines: Methods and Protocols. Methods in Molecular Biology, vol. 1694, Humana Press, New York, pp. 469-488. https://doi.org/10.1007/978-1-4939-7398-9_39
Damiani E, Wallace HM. Polyamines and Cancer. In Alcázar R, Tiburcio A, editors, Polyamines: Methods and Protocols. New York: Humana Press. 2018. p. 469-488. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-7398-9_39
Damiani, Elisabetta ; Wallace, Heather M. / Polyamines and Cancer. Polyamines: Methods and Protocols. editor / R Alcázar ; A Tiburcio . New York : Humana Press, 2018. pp. 469-488 (Methods in Molecular Biology).
@inbook{2a34919e733e499ebe90bfba371cb2b9,
title = "Polyamines and Cancer",
abstract = "This chapter provides an overview of how the polyamine pathway has been exploited as a target for the treatment and prevention of multiple forms of cancer, since this pathway is disrupted in all cancers. It is divided into three main sections. The first explores how the polyamine pathway has been targeted for chemotherapy, starting from the first drug to target it, difluoromethylornithine (DFMO) to the large variety of polyamine analogues that have been synthesised and tested throughout the years with all their potentials and pitfalls. The second section focuses on the use of polyamines as vectors for drug delivery. Knowing that the polyamine transport system is upregulated in cancers and that polyamines naturally bind to DNA, a range of polyamine analogues and polyamine-like structures have been synthesised to target epigenetic regulators, with encouraging results. Furthermore, the use of polyamines as transport vectors to introduce toxic/bioactive/fluorescent agents more selectively to the intended target in cancer cells is discussed. The last section concentrates on chemoprevention, where the different strategies that have been undertaken to interfere with polyamine metabolism and function for antiproliferative intervention are outlined and discussed.",
keywords = "Polyamines, Cancer , Chemoprevention, Chemotherapy, Drug Delivery",
author = "Elisabetta Damiani and Wallace, {Heather M}",
year = "2018",
doi = "10.1007/978-1-4939-7398-9_39",
language = "English",
isbn = "978-1-4939-7397-2",
series = "Methods in Molecular Biology",
publisher = "Humana Press",
pages = "469--488",
editor = "R Alc{\'a}zar and {Tiburcio }, A",
booktitle = "Polyamines",

}

TY - CHAP

T1 - Polyamines and Cancer

AU - Damiani, Elisabetta

AU - Wallace, Heather M

PY - 2018

Y1 - 2018

N2 - This chapter provides an overview of how the polyamine pathway has been exploited as a target for the treatment and prevention of multiple forms of cancer, since this pathway is disrupted in all cancers. It is divided into three main sections. The first explores how the polyamine pathway has been targeted for chemotherapy, starting from the first drug to target it, difluoromethylornithine (DFMO) to the large variety of polyamine analogues that have been synthesised and tested throughout the years with all their potentials and pitfalls. The second section focuses on the use of polyamines as vectors for drug delivery. Knowing that the polyamine transport system is upregulated in cancers and that polyamines naturally bind to DNA, a range of polyamine analogues and polyamine-like structures have been synthesised to target epigenetic regulators, with encouraging results. Furthermore, the use of polyamines as transport vectors to introduce toxic/bioactive/fluorescent agents more selectively to the intended target in cancer cells is discussed. The last section concentrates on chemoprevention, where the different strategies that have been undertaken to interfere with polyamine metabolism and function for antiproliferative intervention are outlined and discussed.

AB - This chapter provides an overview of how the polyamine pathway has been exploited as a target for the treatment and prevention of multiple forms of cancer, since this pathway is disrupted in all cancers. It is divided into three main sections. The first explores how the polyamine pathway has been targeted for chemotherapy, starting from the first drug to target it, difluoromethylornithine (DFMO) to the large variety of polyamine analogues that have been synthesised and tested throughout the years with all their potentials and pitfalls. The second section focuses on the use of polyamines as vectors for drug delivery. Knowing that the polyamine transport system is upregulated in cancers and that polyamines naturally bind to DNA, a range of polyamine analogues and polyamine-like structures have been synthesised to target epigenetic regulators, with encouraging results. Furthermore, the use of polyamines as transport vectors to introduce toxic/bioactive/fluorescent agents more selectively to the intended target in cancer cells is discussed. The last section concentrates on chemoprevention, where the different strategies that have been undertaken to interfere with polyamine metabolism and function for antiproliferative intervention are outlined and discussed.

KW - Polyamines

KW - Cancer

KW - Chemoprevention

KW - Chemotherapy

KW - Drug Delivery

U2 - 10.1007/978-1-4939-7398-9_39

DO - 10.1007/978-1-4939-7398-9_39

M3 - Chapter

SN - 978-1-4939-7397-2

T3 - Methods in Molecular Biology

SP - 469

EP - 488

BT - Polyamines

A2 - Alcázar, R

A2 - Tiburcio , A

PB - Humana Press

CY - New York

ER -